ELOX·29014R103·UW·equity·Healthcare - Biotechnology-13D/G
ELOX (Eloxx Pharmaceuticals, Inc.) is held by 0 institutional investors as of Q1 2024.
See how ELOX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer